The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
CpG DNA as a vaccine adjuvant
Open accessAbstract
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) to mount an innate immune response characterized by the production of Th1 and proinflammatory cytokines. When used as vaccine adjuvants, CpG ODNs improve the function of professional antigen-presenting cells and boost the generation of humoral and cellular vaccine-specific immune responses. These effects are optimized by maintaining ODNs and vaccine in close proximity. The adjuvant properties of CpG ODNs are observed when administered either systemically or mucosally, and persist in immunocompromised hosts. Preclinical studies indicate that CpG ODNs improve the activity of vaccines targeting infectious diseases and cancer. Clinical trials demonstrate that CpG ODNs have a good safety profile and increase the immunogenicity of coadministered vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 6×
“Only transfection with TLR-9 conferred responsiveness to CpG ODNs or bacterial DNA [9,10].”
BackgroundInfluentialDirect Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationPathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., & Krieg, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,477
Self-citationMaintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., & Taniguchi, T. (2005) · Nature · doi:10.1038/nature03547 · Cited by 912
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.
Field, A. K., Tytell, A. A., Lampson, G. P., & Hilleman, M. R. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.3.1004 · Cited by 708
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Gene inoculation generates immune responses against human immunodeficiency virus type 1.
Wang, B., Ugen, K. E., Srikantan, V, Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V., & Weiner, D. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4156 · Cited by 655
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
Hartmann, G., Weiner, G. J., & Krieg, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9305 · Cited by 626
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Leishmaniasis: Current Status of Vaccine Development
Handman, E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.229-243.2001 · Cited by 600
Hartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K. J., Takeshita, S., Gursel, M., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3555 · Cited by 570
Self-citationMacrophages ingest and are activated by bacterial DNA
Stacey, K. J., Sweet, M. J., & Hume, D. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2116 · Cited by 570
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T., & Klinenberg, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.117 · Cited by 549
Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., & Vogel, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3042 · Cited by 541
Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2372 · Cited by 529
Self-citationWeiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Heinzel, F. P., Sadick, M. D., Mutha, S. S., & Locksley, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7011 · Cited by 517
Contribution of CpG motifs to the immunogenicity of DNA vaccines
Klinman, D. M., Yamshchikov, G., & Ishigatsubo, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3635 · Cited by 507
Self-citationSteinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Self-citationIn Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., Kim, Y. H., Hoppe, R. T., Knox, S. J., Shin, L. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9793 · Cited by 487
Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., & Tokunaga, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4072 · Cited by 468
Häcker, H., Vabulas, R. M., Takeuchi, O., Hoshino, K., Akira, S., & Wagner, H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.595 · Cited by 468
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
Sedegah, M., Hedstrom, R., Hobart, P., & Hoffman, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9866 · Cited by 447
Toll‐like receptor stimulation as a third signal required for activation of human naive B cells
Ruprecht, C. R., & Lanzavecchia, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535744 · Cited by 436
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432
Cowdery, J. S., Chace, J. H., Yi, A. K., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4570 · Cited by 423
Chlamydia Infections and Heart Disease Linked Through Antigenic Mimicry
Bachmaier, K., Neu, N., de la Maza, L. M., Pal, S., Hessel, A., & Penninger, J. M. (1999) · Science · doi:10.1126/science.283.5406.1335 · Cited by 419
Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock
Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Häcker, H., Heeg, K., & Wagner, H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270712 · Cited by 416
Bacterial DNA causes septic shock
Sparwasser, T., Miethke, T., Lipford, G., Borschert, K., Häcker, H., Heeg, K., & Wagner, H. (1997) · Nature · doi:10.1038/386336a0 · Cited by 411
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Halpern, M. D., Kurlander, R. J., & Pisetsky, D. S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0009 · Cited by 391
Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K.-D., Coffman, R. L., & Barrat, F. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060401 · Cited by 391
TLR9 as a key receptor for the recognition of DNA☆
KUMAGAI, Y., TAKEUCHI, O., & AKIRA, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.12.004 · Cited by 387
Tighe, H., Takabayashi, K., Schwartz, D., Van Nest, G., Tuck, S., Eiden, J. J., Kagey-Sobotka, A., Creticos, P. S., Lichtenstein, L. M., Spiegelberg, H. L., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107927 · Cited by 385
Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H., & Heeg, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 383
Krieg, A. M., Love-Homan, L., Yi, A.-K., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 379
Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T., & Tokunaga, T. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02102.x · Cited by 366
Type I Interferon-mediated Stimulation of T Cells by CpG DNA
Sun, S., Zhang, X., Tough, D. F., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2335 · Cited by 361
Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T., Endres, S., & Hartmann, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4465 · Cited by 352
Millan, C. L. B., Weeratna, R., Krieg, A. M., Siegrist, C.-A., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15553 · Cited by 345
Pacanowski, J., Kahi, S., Baillet, M., Lebon, P., Deveau, C., Goujard, C., Meyer, L., Oksenhendler, E., Sinet, M., & Hosmalin, A. (2001) · Blood · doi:10.1182/blood.v98.10.3016 · Cited by 343
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA
Cox, G. J., Zamb, T. J., & Babiuk, L. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5664-5667.1993 · Cited by 342
COOPER, C. L., DAVIS, H. L., MORRIS, M. L., EFLER, S. M., ADHAMI, M. A., KRIEG, A. M., CAMERON, D. W., & HEATHCOTE, J. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6244-3 · Cited by 330
Yi, A.-K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4755 · Cited by 328
The Cellular and Subcellular Bases of Immunosenescence
Thoman, M. L., & Weigle, W. O. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60655-0 · Cited by 318
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 310
CpG motifs as immune adjuvants
Klinman, D. M., Barnhart, K. M., & Conover, J. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00151-0 · Cited by 308
Self-citationDevelopmental Aspects of Immunity
Šterzl, J., & Silverstein, A. M. (1967) · Advances in Immunology · doi:10.1016/s0065-2776(08)60525-8 · Cited by 303
Valmori, D., Souleimanian, N. E., Tosello, V., Bhardwaj, N., Adams, S., O'Neill, D., Pavlick, A., Escalon, J. B., Cruz, C. M., Angiulli, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703395104 · Cited by 299
Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., & Endres, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323813 · Cited by 296
Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells
Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J.-P., Wagner, H., & Lipford, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5000 · Cited by 293
Activation of human B cells by phosphorothioate oligodeoxynucleotides.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S., & Lipsky, P. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118894 · Cited by 287
Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5394 · Cited by 281
Self-citationWille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052433 · Cited by 275
McCluskie, M. J., & Davis, H. L. (1998) · PubMed · Cited by 264
Halperin, S. A., Van Nest, G., Smith, B., Abtahi, S., Whiley, H., & Eiden, J. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00045-8 · Cited by 259
Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., & Van Nest, G. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202630 · Cited by 259
Endotoxins and Other Sepsis Triggers
Opal, S. M. (2010) · Contributions to Nephrology · doi:10.1159/000315915 · Cited by 256
Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokines
Lipford, G. B., Sparwasser, T., Bauer, M., Zimmermann, S., Koch, E., Heeg, K., & Wagner, H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271242 · Cited by 251
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
Cooper, C. L., Davis, H. L., Morris, M. L., Efler, S. M., Krieg, A. M., Li, Y., Laframboise, C., Al Adhami, M. J., Khaliq, Y., Seguin, I., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.058 · Cited by 248
Pervasive CpG suppression in animal mitochondrial genomes
Cardon, L. R., Burge, C., Clayton, D. A., & Karlin, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3799 · Cited by 238
McCluskie, M. J., & Davis, H. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4463 · Cited by 237
Rankin, R., Pontarollo, R., Ioannou, X., Krieg, A. M., Hecker, R., Babiuk, L. A., & van Drunen Littel-van den Hurk, S. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001753231713 · Cited by 235
Gallichan, W. S., Woolstencroft, R. N., Guarasci, T., McCluskie, M. J., Davis, H. L., & Rosenthal, K. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3451 · Cited by 220
Gürsel, M., Verthelyi, D., Gürsel, I., Ishii, K. J., & Klinman, D. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.813 · Cited by 214
Self-citationStrategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides
Mutwiri, G. K., Nichani, A. K., Babiuk, S., & Babiuk, L. A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.022 · Cited by 208
Upon TLR9 Signaling, CD5+ B Cells Control the IL-12-Dependent Th1-Priming Capacity of Neonatal DCs
Sun, C.-M., Deriaud, E., Leclerc, C., & Lo-Man, R. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.008 · Cited by 204
Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA.
Gilkeson, G. S., Grudier, J. P., Karounos, D. G., & Pisetsky, D. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1482 · Cited by 203
CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1659 · Cited by 199
Self-citationRomani, L., Mencacci, A., Grohmann, U., Mocci, S., Mosci, P., Puccetti, P., & Bistoni, F. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.19 · Cited by 195
Dna Methylation and its Possible Biological Roles
Razin, A., & Friedman, J. (1981) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60482-1 · Cited by 194
Cooper, C. L., Davis, H. L., Angel, J. B., Morris, M. L., Elfer, S. M., Seguin, I., Krieg, A. M., & Cameron, D. W. (2005) · AIDS · doi:10.1097/01.aids.0000183514.37513.d2 · Cited by 191
Studies of human cord blood dendritic cells: evidence for functional immaturity
Hunt, D., Huppertz, H., Jiang, H., & Petty, R. (1994) · Blood · doi:10.1182/blood.v84.12.4333.bloodjournal84124333 · Cited by 189
Krieg, A. M., Efler, S. M., Wittpoth, M., Al Adhami, M. J., & Davis, H. L. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200411000-00006 · Cited by 184
Gursel, I., Gursel, M., Ishii, K. J., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3324 · Cited by 182
Self-citationGilkeson, G. S., Pippen, A. M., & Pisetsky, D. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117793 · Cited by 177
Do DNA Vaccines Induce Autoimmune Disease?
Mor, G., Singla, M., Steinberg, A. D., Hoffman, S. L., Okuda, K., & Klinman, D. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.3-293 · Cited by 177
Self-citationJones, T. R., Obaldia, N., Gramzinski, R. A., Charoenvit, Y., Kolodny, N., Kitov, S., Davis, H. L., Krieg, A. M., & Hoffman, S. L. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00145-0 · Cited by 167
Microbial products induce autoimmune disease by an IL-12-dependent pathway
Segal, B. M., Klinman, D. M., & Shevach, E. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5087 · Cited by 166
Self-citationKlinman, D. M., Conover, J., & Coban, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5658-5663.1999 · Cited by 163
Self-citationKovarik, J., Bozzotti, P., Love-Homan, L., Pihlgren, M., Davis, H. L., Lambert, P.-H., Krieg, A. M., & Siegrist, C.-A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1611 · Cited by 160
McCluskie, M. J., & Davis, H. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00208-5 · Cited by 157
CpG DNA: A pathogenic factor in systemic lupus erythematosus?
Krieg, A. Μ. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01541318 · Cited by 155
Segal, B. M., Chang, J. T., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5683 · Cited by 153
Adjuvant Activity of CpG Oligodeoxynucleotides
Klinman, D. M. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743057 · Cited by 148
Self-citationInduction of neonatal tolerance by plasmid DNA vaccination of mice.
Mor, G., Yamshchikov, G. V., Sedegah, M., Takeno, M., Wang, R., Houghten, R. A., Hoffman, S. L., & Klinman, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119094 · Cited by 130
Self-citationIshii, K. J., Takeshita, F., Gürsel, İ., Gürsel, M., Conover, J., Nussenzweig, A., & Klinman, D. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020773 · Cited by 130
Self-citationvon Stebut, E., Belkaid, Y., Nguyen, B. V., Cushing, M. M., Sacks, D. L., & Udey, M. C. (2000) · European Journal of Immunology · Cited by 128
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.
Monteith, D. K. B., Henry, S. P., Rb, H., et al. (1997) · PubMed · Cited by 124
Crompton, P. D., Traoré, B., Kayentao, K., Doumbo, S., Ongoïba, A., Diakité, S. A. S., Krause, M., Doumtabé, D., Koné, Y., Weiss, G. E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592224 · Cited by 121
Immune Recognition of Foreign DNA
Klinman, D. M., Verthelyi, D. I., Takeshita, F., & Ishii, K. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80087-4 · Cited by 116
Self-citationRothenfußer, S., Hornung, V., Ayyoub, M., Britsch, S., Towarowski, A., Krug, A., Sarris, A., Lübenow, N., Speiser, D. E., Endres, S., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1091 · Cited by 116
Accessing the therapeutic potential of immunostimulatory nucleic acids
Barchet, W., Wimmenauer, V., Schlee, M., & Hartmann, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.007 · Cited by 114
CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection
Verthelyi, D. I., Gürsel, M., Kenney, R. T., Lifson, J. D., Liu, S., Mican, J., & Klinman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4717 · Cited by 113
Self-citationSøgaard, O. S., Lohse, N., Harboe, Z. B., Offersen, R., Bukh, A., Davis, H. L., Schønheyder, H. C., & Østergaard, L. J. (2010) · Clinical Infectious Diseases · doi:10.1086/653112 · Cited by 112
Karbach, J., Gnjatic, S., Bender, A., Neumann, A., Weidmann, E., Yuan, J. D., Ferrara, C. A., Hoffmann, E. W., Old, L. J., Altorki, N. K., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24850 · Cited by 111
Iho, S., Yamamoto, T., Takahashi, T., & Yamamoto, S. (1999) · PubMed · Cited by 110
Fourcade, J. J., Kudela, P., Filho, P. A. A., Janjic, B. M., Land, S. R., Sander, C., Krieg, A. Μ., Donnenberg, A. D., Shen, H., Kirkwood, J. M., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318183af0b · Cited by 109
Xie, H., Gürsel, İ., Ivins, B. E., Singh, M., O’Hagan, D. T., Ulmer, J. B., & Klinman, D. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.828-833.2005 · Cited by 109
Self-citationEffect of Suppressive DNA on CpG-Induced Immune Activation
Yamada, H., Gürsel, İ., Takeshita, F., Conover, J., Ishii, K. J., Gürsel, M., Takeshita, S., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5590 · Cited by 109
Self-citationSiegrist, C., Pihlgren, M., Tougne, C., Efler, S. M., Morris, M. L., Al-Adhami, M., Cameron, D. W., Cooper, C., Heathcote, J., Davis, H. L., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.014 · Cited by 108
Mullen, G. E. D., Ellis, R. D., Miura, K., Malkin, E. M., Nolan, C., Hay, M., Fay, M. P., Saul, A. J., Zhu, D., Rausch, K. M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002940 · Cited by 107
Sandler, A. D., Chihara, H., Kobayashi, G., Zhu, X., Miller, M. A., Scott, D. L., & Krieg, A. Μ. (2003) · PubMed · Cited by 106
Sen, G., Khan, A. Q., Chen, Q., & Snapper, C. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3084 · Cited by 103
Procaryotic and eucaryotic traits of DNA methylation in spiroplasmas (mycoplasmas)
Nur, I., Moshe Szyf, A., Razin, A., Glaser, G., Rottem, S., & Razin, S. (1985) · Journal of Bacteriology · doi:10.1128/jb.164.1.19-24.1985 · Cited by 102
Yamamoto, T., Yamamoto, S., Kataoka, T., & Tokunaga, T. (1994) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1994.tb01867.x · Cited by 98
Cooper, C., Angel, J. B., Seguin, I., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/533467 · Cited by 97
Klinman, D. M., Xie, H., Little, S. F., Currie, D., & Ivins, B. E. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.020 · Cited by 95
Self-citationImmunostimulatory DNA Prepriming: A Novel Approach for Prolonged Th1-Biased Immunity
Kobayashi, H., Horner, A. A., Takabayashi, K., Nguyen, M.-D., Huang, E., Cinman, N., & Raz, E. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1572 · Cited by 94
Hartmann, G., Krug, A., Waller-Fontaine, K., & Endres, S. (1996) · Molecular Medicine · doi:10.1007/bf03401902 · Cited by 89
Therapeutic Applications of CpG-Containing Oligodeoxynucleotides
Klinman, D. M. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.181 · Cited by 89
Self-citationDNA vaccines: safety and efficacy issues
Klinman, D. M., Takeno, M., Ichino, M., Gu, M., Yamshchikov, G. V., Mor, G., & Conover, J. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00870272 · Cited by 88
Self-citationFogg, C. N., Americo, J. L., Lustig, S., Huggins, J. W., Smith, S. K., Damon, I. K., Resch, W., Earl, P. L., Klinman, D. M., & Moss, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.037 · Cited by 85
Self-citationMéndez, S., Tabbara, K. S., Belkaid, Y., Bertholet, S., Verthelyi, D. I., Klinman, D. M., Seder, R. A., & Sacks, D. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5121-5129.2003 · Cited by 85
Self-citationSagara, I., Ellis, R. D., Dicko, A., Niambele, M. B., Kamaté, B., Guindo, O., Sissoko, M. S., Fay, M. P., Guindo, M. A., Kante, O., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.087 · Cited by 84
Samulowitz, U., Weber, M., Weeratna, R. D., Uhlmann, E., Noll, B. O., Krieg, A. Μ., & Vollmer, J. (2010) · Oligonucleotides · doi:10.1089/oli.2009.0210 · Cited by 82
Mukherjee, P., Pathangey, L. B., Bradley, J. B., Tinder, T. L., Basu, G. D., Akporiaye, E. T., & Gendler, S. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.007 · Cited by 81
The Cell Biology of Aging: Immunological Models
Miller, R. A. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.1.b4 · Cited by 78
CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
Haining, W. N., DAVIES, J. K., Kanzler, H., Drury, L., Brenn, T., Evans, J., Angelosanto, J., Rivoli, S., Russell, K. E. R., George, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0526 · Cited by 76
Tengvall, S., Lundqvist, A., Eisenberg, R. J., Cohen, G. H., & Harandi, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02013-05 · Cited by 74
Eastcott, J. W., Holmberg, C. J., Dewhirst, F. E., Esch, T. R., Smith, D. J., & Taubman, M. A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00422-9 · Cited by 70
Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis
Zeuner, R. A., Verthelyi, D. I., Gürsel, M., Ishii, K. J., & Klinman, D. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11035 · Cited by 68
Self-citationInduction of Immune-Mediated Glomerulonephritis in Normal Mice Immunized with Bacterial DNA
Gilkeson, G. S., Ruiz, P., Howell, D. N., Lefkowith, J. B., & Pisetsky, D. S. (1993) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1993.1129 · Cited by 64
Distinct Response of Human B Cell Subpopulations in Recognition of an Innate Immune Signal, CpG DNA
Jung, J., Yi, A., Zhang, X., Choe, J., Li, L., & Choi, Y. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2368 · Cited by 60
Chiaramonte, M. G., Hesse, M., Cheever, A. W., & Wynn, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.973 · Cited by 55
Dendritic cells and innate defense against tumor cells
Ullrich, E., Menard, C., Flament, C., Terme, M., Mignot, G., Bonmort, M., Plumas, J., Chaperot, L., Chaput, N., & Zitvogel, L. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.009 · Cited by 54
Sen, G., Chen, Q., & Snapper, C. M. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2177-2186.2006 · Cited by 54
Verthelyi, D. I., Wang, V. W., Lifson, J. D., & Klinman, D. M. (2004) · AIDS · doi:10.1097/00002030-200404300-00007 · Cited by 53
Self-citationNesburn, A. B., Ramos, T., Zhu, X., Asgarzadeh, H., Nguyen, V., & BenMohamed, L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.019 · Cited by 52
Traoré, B., Koné, Y., Doumbo, S., Doumtabé, D., Traoré, A., Crompton, P. D., Mircetic, M., Huang, C., Kayentao, K., Dicko, A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.023 · Cited by 51
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
Muraoka, D., Kato, T., Wang, L., Maeda, Y., Noguchi, T., Harada, N., Takeda, K., Yagita∥, H., Guillaume, P., Luescher, I. F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903649 · Cited by 50
Amplification of antibody production by phosphorothioate oligodeoxynucleotides
Branda, R. F., Moore, A. L., Lafayette, A., Mathews, L., Hong, R., Zon, G., Brown, T., & McCormack, J. J. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90035-9 · Cited by 47
Short- and long-term changes in gene expression mediated by the activation of TLR9
Klaschik, S., Tross, D., Shirota, H., & Klinman, D. M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.11.014 · Cited by 46
Self-citationInductive and suppressive networks regulate TLR9-dependent gene expression in vivo
Klaschik, S., Tross, D., & Klinman, D. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008671 · Cited by 44
Self-citationMapletoft, J. W., Oumouna, M., Townsend, H. G. G., Gomis, S. M., Babiuk, L. A., & den Hurk, S. V. D. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.001 · Cited by 36
Ishii, K. J., Weiss, W. R., & Klinman, D. M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00267-4 · Cited by 31
Self-citationCpG-activated Thy1.2+ dendritic cells protect against lethalListeria monocytogenes infection
Ishii, K. J., Ito, S., Tamura, T., Hemmi, H., Conover, J., Ozato, K., Akira, S., & Klinman, D. M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425795 · Cited by 31
Self-citationCpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.
Qin, W., Jiang, J., Chen, Q., Yang, N., Wang, Y., Wei, X., & Ou, R. (2004) · PubMed · Cited by 28
Linghua, Z., Xingshan, T., & Fengzhen, Z. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.058 · Cited by 26
CpG‐enhanced CD8+ T‐cell responses to peptide immunization are severely inhibited by B cells
Overstreet, M. G., Freyberger, H. R., Cockburn, I. A., Chen, Y., Tse, S., & Zavala, F. P. (2009) · European Journal of Immunology · doi:10.1002/eji.200939493 · Cited by 25
CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells
Kato, A., Ogasawara, T., Homma, T., Batchelor, J., Imai, S., Wakiguchi, H., Saito, H., & Matsumoto, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.059 · Cited by 23
Huang, C., Wang, C., Wu, T., Wu, K., Lee, C., & Peng, H. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318156050d · Cited by 20
Consequences of Bacterial CpG DNA-Driven Activation of Antigen-Presenting Cells
Sparwasser, T. D., & Lipford, G. B. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_4 · Cited by 14
Research works printed but not linked: 22
- Paul WE. Fundamental Immunology . Raven Press, New York, NY, USA (1993).
- Tross, 2008, J. Immunol., 181, 5785, 10.4049/jimmunol.181.8.5785 · doi:10.4049/jimmunol.181.8.5785
- 10.4049/jimmunol.168.12.6099 · doi:10.4049/jimmunol.168.12.6099
- Sandler, 2003, Cancer Res., 63, 394
- von Hunolstein, 2001, Vaccine, 19, 3058, 10.1016/S0264-410X(01)00048-2 · doi:10.1016/s0264-410x(01)00048-2
- Al Mariri, 2001, Infect. Immun., 69, 4816, 10.1128/IAI.69.8.4816-4822.2001 · doi:10.1128/iai.69.8.4816-4822.2001
- Klinman, 2007, Microbes Infect., 9, 1478, 10.1016/j.micinf.2007.08.002 · doi:10.1016/j.micinf.2007.08.002
- Qin, 2004, Cell. Mol. Immunol., 1, 148
- Diamant, 1993, Pediatr. Infect. Dis. J., 12, 877, 10.1097/00006454-199310000-00014 · doi:10.1097/00006454-199310000-00014
- Wong, 1996, Int. J. STD AIDS, 7, 490, 10.1258/0956462961918563 · doi:10.1258/0956462961918563
- Linghua, 2007, Vet. Immunol. Immunopathol., 115, 216, 10.1016/j.vetimm.2006.10.017 · doi:10.1016/j.vetimm.2006.10.017
- Davis, 2000, Vaccine, 18, 1920, 10.1016/S0264-410X(99)00443-0 · doi:10.1016/s0264-410x(99)00443-0
- Steinhagen, 2010, Vaccine
- 10.1172/JCI23373 · doi:10.1172/jci23373 · Paper page
- Steinberg, 1990, Immunol. Rev., 118, 129, 10.1111/j.1600-065X.1990.tb00815.x · doi:10.1111/j.1600-065x.1990.tb00815.x
- Klinman, 1990, J. Clin. Invest., 86, 1249, 10.1172/JCI114831 · doi:10.1172/jci114831
- Yi, 1996, J. Immunol., 157, 4918, 10.4049/jimmunol.157.11.4918 · doi:10.4049/jimmunol.157.11.4918
- Katsumi, 1994, Hum. Gene Ther., 5, 1335, 10.1089/hum.1994.5.11-1335 · doi:10.1089/hum.1994.5.11-1335
- Gilkeson, 1998, J. Immunol., 161, 3890, 10.4049/jimmunol.161.8.3890 · doi:10.4049/jimmunol.161.8.3890
- 10.1038/nbt0508-484a · doi:10.1038/nbt0508-484a
- Le, 1999, J. Rheumatol., 26, 191
- Allen, 1993, Thorax, 48, 580, 10.1136/thx.48.5.580 · doi:10.1136/thx.48.5.580
Cited by
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Self-citationStructure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Compound Copper Chalcogenide Nanocrystals
Coughlan, C., Ibáñez, M., Dobrozhan, O., Singh, A., Cabot, A., & Ryan, K. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00376 · Cited by 930
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Metadata
- Authors
- Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 10
- Issue
- 4
- Pages
- 499-511
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2110223801
- Cited by
- 891
- References
- 174
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.